Cited by 26Heart Failure Treatment and ManagementCardiovascular Function and Risk FactorsDiabetes Treatment and Management

Diabetes, quality of care, and in-hospital outcomes in patients hospitalized with heart failure

Kapoor, John R., Fonarow, Gregg C., Zhao, Xin, Kapoor, Roger, Hernandez, Adrian F., Heidenreich, Paul A.·2011·American Heart Journal

Abstract

Background Diabetes mellitus is frequently comorbid with heart failure (HF). It is unclear if comorbid diabetes is associated with quality of care and in-hospital mortality.Methods We analyzed 133,971 HF admissions from 431 hospitals between January 2005 and January 2010 comparing patients with and without diabetes.Results There were 54,352 (41%) patients hospitalized with HF with a history or newly diagnosed diabetes. After adjustment, patients with diabetes were as likely as patients without diabetes to appropriately receive the composite of angiotensin-converting enzyme inhibitor/angiotensin receptor blocker and β-blockers (odds ratio [OR] 0.99, 95% CI 0.94-1.04), angiotensin-converting enzyme inhibitor/angiotensin receptor blocker (OR 0.98, 95% CI 0.92-1.05), evidence-based β-blockers (OR 1.04, 95% CI 0.98-1.1), and hydralazine/nitrates (OR 1.09, 95% CI 0.99-1.2). However, patients with diabetes were less likely to receive smoking cessation counseling (OR 0.89, 95% CI 0.81-0.98) and blood pressure control (OR 0.81, 95% CI 0.78-0.84) and to attain the all-or-none composite measure (OR 0.96, 95% CI 0.93-0.99). Patients with diabetes were more likely to receive an aldosterone antagonist for reduced left ventricular ejection fraction (OR 1.05, 95% CI 1.00-1.11), lipid-lowering agent (OR 1.33, 95% CI 1.26-1.41), and influenza vaccination (OR 1.05, 95% CI 1.01-1.09). Diabetes was independently associated with longer hospital stay but not within-hospital mortality.Conclusions With few exceptions, the application of evidence-based care and in-hospital outcomes were similar whether or not diabetes was present in this large contemporary cohort of patients hospitalized with HF.

Integrity signals

Registry

Crossref · 10.1016/j.ahj.2011.06.008

Cites

26 of 26 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

1 of the 27 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Kapoor, J. R., Fonarow, G. C., Zhao, X., Kapoor, R., Hernandez, A. F., & Heidenreich, P. A.
Affiliations
  • University of Chicago (US)
  • University of California, Los Angeles (US)
  • Duke Clinical Research Institute (US)
  • Harvard University (US)
  • VA Palo Alto Health Care System (US)
Corresponding author
Kapoor, John R.
Venue
American Heart Journal
Publisher
Elsevier BV
Published
2011-09
Volume
162
Issue
3
Pages
480-486.e3
ISSN
0002-8703 (ISSN-L)
OpenAlex
W2100397067
Cited by
26
References
27
Citations by year
2026: 1 · 2023: 1 · 2022: 3 · 2021: 1 · 2019: 4 · 2018: 6 · 2017: 1 · 2016: 2 · 2015: 2 · 2014: 2 · 2013: 1 · 2012: 2
FWCI
1.10
Type
journal article
Language
en
Open access
closed
Locations
  • American Heart Journal (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Novartis
  • Medtronic
  • National Heart, Lung, and Blood Institute
  • GlaxoSmithKline
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
Keywords
diabetes mellitus, heart failure, quality of care, in-hospital mortality, guideline-directed therapy, ACE inhibitors, angiotensin receptor blockers, beta-blockers, smoking cessation counseling, blood pressure control, mineralocorticoid receptor antagonists, lipid-lowering drugs, influenza vaccination, length of hospital stay, comorbidities
MeSH terms
Aged, Diabetes Mellitus, Female, Heart Failure, Humans, Inpatients, Male, Prospective Studies, Quality of Health Care, United States, Comorbidity, Incidence, Hospital Mortality

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review